{"id":"W2548525236","doi":"10.1016/j.radonc.2016.10.019","title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy","year":2016,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Canadian Association of Radiation Oncology","keywords":"Prostate cancer; Medicine; Brachytherapy; Toxicity; Prostate; Randomized controlled trial; Oncology; Clinical trial; Urology; Quality of life (healthcare); Internal medicine; Radiation therapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002078661,0.0002612071,0.002571197,0.0001469631,0.00007852892,0.000007338137,0.00005900615,0.0002304212,0.00005753378],"category_scores_gemma":[0.0008383713,0.0001628447,0.0002294735,0.0001151996,0.0008681367,0.0001504191,0.00001833687,0.0001667974,1.070184e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001271452,"about_ca_system_score_gemma":0.0005344214,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006709457,"about_ca_topic_score_gemma":0.0007640207,"domain_scores_codex":[0.9961494,0.0009081353,0.002037365,0.0005042831,0.0001689669,0.0002318623],"domain_scores_gemma":[0.9902816,0.006532745,0.002448226,0.0002896251,0.0002557859,0.0001919528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7307895,0.003738264,0.008792979,0.0001210703,0.001881793,0.000002292565,0.002200271,0.000002182051,0.02363876,0.00006020241,0.00002410212,0.2287486],"study_design_scores_gemma":[0.9016287,0.04766107,0.02139416,0.0004075651,0.0004635978,0.000002083737,0.00009584867,0.000128341,0.0259288,0.001214462,0.000905296,0.0001701198],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862794,0.004429292,0.0009211596,0.001971945,0.0003223725,0.00415793,0.001895839,0.00001606757,0.000006054104],"genre_scores_gemma":[0.7905717,0.2068879,0.001480687,0.0002411287,0.0002452459,0.0004601371,0.0000300241,0.00002769579,0.00005541736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2285785,"threshold_uncertainty_score":0.9999049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05755448910480184,"score_gpt":0.4245274407220463,"score_spread":0.3669729516172445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}